How high can Anthem stock go?

How high can Anthem stock go?

Anthem Inc (NYSE:ANTM) The 20 analysts offering 12-month price forecasts for Anthem Inc have a median target of 442.50, with a high estimate of 479.00 and a low estimate of 385.00. The median estimate represents a +17.68% increase from the last price of 376.01.

Is ANTM a buy?

Out of 14 analysts, 6 (42.86%) are recommending ANTM as a Strong Buy, 6 (42.86%) are recommending ANTM as a Buy, 2 (14.29%) are recommending ANTM as a Hold, 0 (0%) are recommending ANTM as a Sell, and 0 (0%) are recommending ANTM as a Strong Sell. What is ANTM’s earnings growth forecast for 2021-2023?

How can I buy Anthem stock?

How to buy shares in Anthem

1. Compare share trading platforms. Use our comparison table to help you find a platform that fits you.
2. Open your brokerage account. Complete an application with your details.
3. Confirm your payment details. Fund your account.
4. Research the stock.
5. Purchase now or later.
6. Check in on your investment.

Is anthem a buy or sell?

Anthem has received a consensus rating of Buy. The company’s average rating score is 2.90, and is based on 18 buy ratings, 2 hold ratings, and no sell ratings.

Is Anthem stock going to split?

Anthem (ANTM) has 0 splits in our Anthem stock split history database. Looking at the Anthem stock split history from start to finish, an original position size of 1000 shares would have turned into 1000 today.

How many times did Anthem stock split?

According to our Anthem stock split history records, Anthem has had 0 splits. Anthem (ANTM) has 0 splits in our Anthem stock split history database. Looking at the Anthem stock split history from start to finish, an original position size of 1000 shares would have turned into 1000 today.

When was the last time anthem stock split?

Prices Before And After ANTM Stock Splits….1 How Many Times Anthem Inc (ANTM) Stock’s Were Split?

Is Cigna stock a buy?

Cigna has received a consensus rating of Buy. The company’s average rating score is 2.94, and is based on 14 buy ratings, 2 hold ratings, and no sell ratings.

Why did Cigna stock drop today?

The recent fall came after the company cautioned about rising Covid-19 related costs. This means health insurance companies will need to shell out more money to pay those bills. Cigna’s CI +0.7% medical costs as a percentage of premium income has risen to 85% in Q2 2021, compared to just 70% in the prior year quarter.

Is Cigna stock undervalued?

Over the past 52 weeks, CI’s PEG has been as high as 1.09 and as low as 0.73, with a median of 0.93. Value investors also use the P/S ratio. These are just a handful of the figures considered in Cigna’s great Value grade. Still, they help show that the stock is likely being undervalued at the moment.

What is the stock price of WellPoint Inc?

WellPoint, Inc., a health benefits company, through its subsidiaries, provides a range of medical products in the United States. The stock closed yesterday’s trading session at $117.52. In the past year, the stock has hit a 52-week low of $81.84 and 52-week high of $124.58.

How many people are members of WellPoint insurance?

Medical enrollment totaled around 37.3 million members as of June 30, 2014, an increase of circa 1.6 million members as of June 30, 2014. All of company’s segments recorded positive growth in revenues in comparison to the same quarter last year.

What is the interest coverage ratio of WellPoint?

The interest coverage ratio of 7.87 is at worse levels than the industry average of 54.25, however, it is still at satisfactory levels.

What is the SG & a expense ratio for WellPoint?

The benefit expense ratio was 82.7%, an improvement in comparison to the same quarter last year ratio of 83.9%. The SG&A expense ratio for the quarter was 15.8%, in comparison to 13.9% for the same quarter of 2013. The deterioration is primarily due to new fees related to Health Care Reform.

WellPoint, Inc., a health benefits company, through its subsidiaries, provides a range of medical products in the United States. The stock closed yesterday’s trading session at $117.52. In the past year, the stock has hit a 52-week low of $81.84 and 52-week high of $124.58.

Medical enrollment totaled around 37.3 million members as of June 30, 2014, an increase of circa 1.6 million members as of June 30, 2014. All of company’s segments recorded positive growth in revenues in comparison to the same quarter last year.

The interest coverage ratio of 7.87 is at worse levels than the industry average of 54.25, however, it is still at satisfactory levels.

The benefit expense ratio was 82.7%, an improvement in comparison to the same quarter last year ratio of 83.9%. The SG&A expense ratio for the quarter was 15.8%, in comparison to 13.9% for the same quarter of 2013. The deterioration is primarily due to new fees related to Health Care Reform.